INSMED INC

About

Insmed Incorporated is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company’s primary commercial product is ARIKAYCE, an antibiotic approved for the treatment of refractory Mycobacterium avium complex lung disease. Insmed is also advancing a pipeline of novel medicines targeting rare pulmonary and immunologic conditions, positioning itself as a leader in niche respiratory markets.